Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DAWN
1976
DELISTED
Day One Biopharmaceuticals
DAWN
| $20M | ﹤0.01% |
1,432,697
+136,458
| +11% | +$1.95M |
|
1977
Lemonade
LMND
$4.1B
| $19.9M | ﹤0.01% |
1,208,613
-64,393
| -5% | -$1.18M |
|
|
SHOE
1978
Shoe Station Group
SHOE
$428M
| $19.8M | ﹤0.01% |
452,548
+10,761
| +2% | +$439K |
|
|
IAS
1979
DELISTED
Integral Ad Science
IAS
| $19.8M | ﹤0.01% |
1,834,659
+110,149
| +6% | +$1.18M |
|
1980
Univest Financial
UVSP
$1.18B
| $19.8M | ﹤0.01% |
704,445
+23,770
| +3% | +$634K |
|
|
PETQ
1981
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $19.7M | ﹤0.01% |
641,387
+4,514
| +0.7% | +$122K |
|
1982
Forward Air
FWRD
$654M
| $19.7M | ﹤0.01% |
556,225
-162,182
| -23% | -$4.6M |
|
1983
Healthcare Services Group
HCSG
$1.53B
| $19.7M | ﹤0.01% |
1,760,971
+50,375
| +3% | +$553K |
|
1984
Evolus
EOLS
$501M
| $19.6M | ﹤0.01% |
1,210,621
+11,027
| +0.9% | +$154K |
|
1985
Mobileye
MBLY
$2.2B
| $19.6M | ﹤0.01% |
1,431,325
+279,082
| +24% | +$4.89M |
|
1986
Embecta
EMBC
$262M
| $19.6M | ﹤0.01% |
1,387,273
+45,228
| +3% | +$658K |
|
1987
Bristow Group
VTOL
$1.36B
| $19.5M | ﹤0.01% |
563,014
+13,320
| +2% | +$481K |
|
1988
Wolfspeed
WOLF
$1.71B
| $19.5M | ﹤0.01% |
2,012,185
-54,368
| -3% | -$800K |
|
1989
Core Laboratories
CLB
$521M
| $19.5M | ﹤0.01% |
1,053,204
+7,721
| +0.7% | +$155K |
|
1990
Sonic Automotive
SAH
$2.61B
| $19.5M | ﹤0.01% |
333,642
+311
| +0.1% | +$17.9K |
|
1991
HealthStream
HSTM
$840M
| $19.5M | ﹤0.01% |
674,764
+18,779
| +3% | +$538K |
|
1992
Ceco Environmental
CECO
$4.14B
| $19.4M | ﹤0.01% |
689,487
+11,857
| +2% | +$334K |
|
1993
Wabash National
WNC
$527M
| $19.4M | ﹤0.01% |
1,011,208
-11,313
| -1% | -$228K |
|
1994
Relay Therapeutics
RLAY
$4.33B
| $19.3M | ﹤0.01% |
2,732,270
+367,473
| +16% | +$2.75M |
|
1995
Grid Dynamics Holdings
GDYN
$615M
| $19.3M | ﹤0.01% |
1,381,429
+17,763
| +1% | +$230K |
|
1996
Scholastic
SCHL
$792M
| $19.3M | ﹤0.01% |
603,481
+283
| +0% | +$9.04K |
|
|
HSII
1997
DELISTED
Heidrick & Struggles
HSII
| $19.3M | ﹤0.01% |
495,513
+18,771
| +4% | +$679K |
|
1998
Hain Celestial
HAIN
$53.7M
| $19.2M | ﹤0.01% |
2,229,181
+142,097
| +7% | +$1.06M |
|
|
PYCR
1999
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $19.2M | ﹤0.01% |
1,354,846
+132,662
| +11% | +$1.76M |
|
2000
Enliven Therapeutics
ELVN
$4.43B
| $19.2M | ﹤0.01% |
750,208
+67,813
| +10% | +$1.57M |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.